Is CT or FDG-PET more useful for evaluation of the treatment response in metastatic HER2-positive breast cancer? a case report and literature review
Response evaluation criteria in solid tumors version 1.1 (RECIST ver1.1) has been widely adopted to evaluate treatment efficacy in solid tumors, including breast cancer (BC), in clinical trials and clinical practice. RECIST is based mainly on computed tomography (CT) images, and the role of fluorode...
Main Authors: | Hirotaka Suto, Yumiko Inui, Atsuo Okamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1158797/full |
Similar Items
-
FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
by: Fredrik Helland, et al.
Published: (2019-08-01) -
Dedifferentiated liposarcoma lung metastases with different FDG-PET/CT findings
by: Yoshito Imamura, et al.
Published: (2023-05-01) -
Case report: Low-grade myofibroblastic sarcoma resembling lymphoma on 18F-FDG PET/CT
by: Huan Zhang, et al.
Published: (2023-03-01) -
The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
by: Maria V. Mattoli, et al.
Published: (2012-01-01) -
An incidental male breast cancer of 18F-FDG PET/CT scanning for esophageal cancer
by: Wenyu Shi, et al.
Published: (2023-04-01)